EXOSENS PROM (EXENS) - Net Assets

Latest as of June 2026: €450.80 Million EUR ≈ $527.03 Million USD

Based on the latest financial reports, EXOSENS PROM (EXENS) has net assets worth €450.80 Million EUR (≈ $527.03 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€895.00 Million ≈ $1.05 Billion USD) and total liabilities (€444.20 Million ≈ $519.32 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check EXOSENS PROM PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric Value
Current Net Assets €450.80 Million
% of Total Assets 50.37%
Annual Growth Rate 35.63%
5-Year Change 158.91%
10-Year Change N/A
Growth Volatility 40.54

EXOSENS PROM - Net Assets Trend (2020–2025)

This chart illustrates how EXOSENS PROM's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see EXOSENS PROM market capitalisation.

Annual Net Assets for EXOSENS PROM (2020–2025)

The table below shows the annual net assets of EXOSENS PROM from 2020 to 2025. Also explore net asset growth rate of EXOSENS PROM to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2025-12-31 €445.60 Million
≈ $520.95 Million
+8.00%
2024-12-31 €412.60 Million
≈ $482.37 Million
+102.19%
2023-12-31 €204.06 Million
≈ $238.57 Million
+11.48%
2022-12-31 €183.05 Million
≈ $214.01 Million
+6.36%
2021-12-31 €172.11 Million
≈ $201.21 Million
+77.25%
2020-12-31 €97.10 Million
≈ $113.52 Million
--

Equity Component Analysis

This analysis shows how different components contribute to EXOSENS PROM's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 11036000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings €94.53 Million 21.21%
Common Stock €21.60 Million 4.85%
Other Comprehensive Income €-8.50 Million -1.91%
Other Components €338.07 Million 75.85%
Total Equity €445.70 Million 100.00%

EXOSENS PROM Competitors by Market Cap

The table below lists competitors of EXOSENS PROM ranked by their market capitalization.

Company Market Cap
Shanghai Fullhan Microelectronics Co Ltd
SHE:300613
$2.85 Billion
Shanghai V-Test Semiconductor Tech Co. Ltd. A
SHG:688372
$2.86 Billion
Resideo Technologies Inc
NYSE:REZI
$2.86 Billion
Banc of California, Inc.
NYSE:BANC
$2.86 Billion
Vicat S.A.
PA:VCT
$2.85 Billion
Premium Brands Holdings Corporation
TO:PBH
$2.85 Billion
Tomra Systems ASA
OL:TOM
$2.85 Billion
TransMedics Group Inc
NASDAQ:TMDX
$2.85 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in EXOSENS PROM's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 412,600,000 to 445,700,000, a change of 33,100,000 (8.0%).
  • Net income of 42,700,000 contributed positively to equity growth.
  • Dividend payments of 5,100,000 reduced retained earnings.
  • Share repurchases of 5,600,000 reduced equity.
  • New share issuances of 4,300,000 increased equity.
  • Other comprehensive income decreased equity by 90,001.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income €42.70 Million +9.58%
Dividends Paid €5.10 Million -1.14%
Share Repurchases €5.60 Million -1.26%
Share Issuances €4.30 Million +0.96%
Other Comprehensive Income €-90.00K -0.02%
Other Changes €-3.11 Million -0.7%
Total Change €- 8.02%

Book Value vs Market Value Analysis

This analysis compares EXOSENS PROM's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 6.95x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 19.04x to 6.95x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2020-12-31 €3.20 €60.85 x
2021-12-31 €5.66 €60.85 x
2022-12-31 €6.02 €60.85 x
2023-12-31 €6.72 €60.85 x
2024-12-31 €8.12 €60.85 x
2025-12-31 €8.75 €60.85 x

Capital Efficiency Dashboard

This dashboard shows how efficiently EXOSENS PROM utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 9.58%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 9.12%
  • • Asset Turnover: 0.53x
  • • Equity Multiplier: 1.97x
  • Recent ROE (9.58%) is above the historical average (-11.88%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2020 -16.30% -10.56% 0.25x 6.16x €-25.54 Million
2021 -86.55% -89.65% 0.36x 2.68x €-166.18 Million
2022 6.13% 5.59% 0.38x 2.89x €-7.09 Million
2023 8.40% 5.38% 0.49x 3.22x €-3.27 Million
2024 7.44% 7.79% 0.48x 1.98x €-10.56 Million
2025 9.58% 9.12% 0.53x 1.97x €-1.87 Million

Industry Comparison

This section compares EXOSENS PROM's net assets metrics with peer companies in the Aerospace & Defense industry.

Industry Context

  • Industry: Aerospace & Defense
  • Average net assets among peers: $2,104,074,361
  • Average return on equity (ROE) among peers: -6.06%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
EXOSENS PROM (EXENS) €450.80 Million -16.30% 0.99x $2.85 Billion
Airbus Group SE (AIR) $6.45 Billion -17.58% 16.08x $136.73 Billion
Dassault Aviation SA (AM) $6.66 Billion 14.67% 3.94x $21.48 Billion
Exail Technologies S.A. (EXA) $64.20 Million 9.52% 2.52x $1.43 Billion
Figeac Aero SA (FGA) $61.07 Million -35.30% 4.86x $487.08 Million
Lisi S.A (FII) $990.42 Million -3.77% 0.88x $2.90 Billion
Thales S.A. (HO) $4.59 Billion 12.77% 3.65x $51.35 Billion
Latécoère S.A. (LAT) $88.70 Million -36.24% 6.12x $201.01 Million
H&K AG (MLHK) $32.39 Million 0.00% 6.05x $1.21 Billion
Verney-Carron S.A (MLVER) $4.84 Million 1.44% 0.47x $1.96 Million

About EXOSENS PROM

PA:EXENS France Aerospace & Defense
Market Cap
$3.61 Billion
€3.08 Billion EUR
Market Cap Rank
#5111 Global
#86 in France
Share Price
€60.85
Change (1 day)
+0.00%
52-Week Range
€41.00 - €72.90
All Time High
€72.90
About

Exosens, together with its subsidiaries, develops, manufactures, and sells electro-optical technologies in France, Europe, North America, Asia, and internationally. It operates in two segments, Amplification and Detection and Imaging. The company offers image intensifier tubes; cameras, sensors, modules and cores, and imaging systems and solutions, including UV missile warning solution, atmospher… Read more